亚太地区阿片类药物市场预测至 2030 年 - 区域分析 - 按产品（速释短效阿片类药物和缓释长效阿片类药物）、应用（疼痛管理、麻醉、腹泻抑制、咳嗽抑制、脱瘾等）、给药途径（口服、注射和透皮贴剂）和分销渠道（医院药房和零售药房）
慢性疼痛发病率飙升推动亚太阿片类药物市场发展
心血管疾病、癌症、肌肉骨骼疾病和神经血管疾病等慢性疾病会降低免疫力，严重影响人体健康。此外，许多患有这些疾病的患者都会经历慢性疼痛。上述疾病在成人和老年人群中最常见。然而，这些疾病的病例在儿童中也明显增加。慢性疼痛在运动员、运动员和过去受过伤的人中也很常见。根据美国国家生物技术信息中心 (NCBI) 发表的一项研究，全球有 20% 的成年人患有疼痛，每年有 10% 的人新诊断出患有慢性疼痛。尽管疼痛影响所有人群，无论性别、种族/民族、收入、年龄或地理位置如何，但它在世界各地的分布并不均匀。处方阿片类药物，包括氢可酮、羟可酮和吗啡，是有效的止痛药，用于治疗由受伤、手术和癌症、关节炎等健康状况引起的疼痛。
阿片类药物处方量的增加可以归因于保险报销计划，这些计划鼓励人们使用阿片类药物而不是替代性疼痛治疗，成本结构鼓励更有效的护理，以及将患者满意度与有效疼痛管理相结合的评估。因此，由于阿片类药物在疼痛管理方面的优势，慢性病患者的需求正在上升。
亚太阿片类药物市场概览
据估计，中国患有绝症的老年人口不断增加，将大大增加对阿片类药物的需求。根据世界卫生组织 (WHO) 的数据，中国是老龄人口增长最快的国家之一。根据同一来源，2019 年 60 岁及以上人口为 2.54 亿，65 岁及以上人口为 1.76 亿。此外，由于预期寿命增加和出生率下降，预计到 2040 年中国 60 岁及以上人口将占总人口的约 28%（4.02 亿人）。老年人口更容易患上与疼痛相关的慢性健康疾病，如关节炎、背痛、癌症等。在这种情况下，阿片类药物用于治疗老年人的慢性疼痛，这极大地影响了中国亚太阿片类药物市场的增长。在中国，患有严重病理性疼痛的新癌症患者数量显著增加。根据 2020 年发表的一项研究“医生继续医学教育对中国癌症疼痛治疗质量的影响”，中国政府鼓励使用阿片类止痛药治疗中度至重度癌症疼痛，这种药物在全国三级医院和二级医院广泛使用。由于阿片类药物是三步止痛阶梯的重要组成部分，并被推荐用于缓解中度和重度癌症疼痛，因此提高对此类疾病和相关治疗的认识可以改善癌症疼痛的治疗方案。
亚太阿片类药物市场收入和预测到 2030 年（百万美元）
亚太阿片类药物市场细分
亚太阿片类药物市场分为产品、应用、给药途径、分销渠道和国家。
根据产品，亚太阿片类药物市场分为速释短效阿片类药物和缓释长效阿片类药物。速释短效阿片类药物部分在 2022 年占据了更大的市场份额。速释短效阿片类药物进一步细分为羟可酮、氢可酮、曲马多、可待因、丙氧芬等。缓释长效阿片类药物进一步细分为羟可酮、芬太尼、吗啡、美沙酮等。
在应用方面，亚太阿片类药物市场分为疼痛管理、麻醉、腹泻抑制、咳嗽抑制、脱瘾等。疼痛管理部分在 2022 年占据了最大的市场份额。
按给药途径，亚太阿片类药物市场分为口服、注射和透皮贴剂。口服药物在 2022 年占据了最大的市场份额。
按分销渠道划分，亚太阿片类药物市场分为医院药房和零售药房。2022 年，医院药房部分占据了更大的市场份额。
按国家划分，亚太阿片类药物市场分为中国、日本、印度、韩国、澳大利亚和亚太其他地区。2022 年，中国占据了亚太阿片类药物市场份额的主导地位。
Endo International plc、Mallinckrodt Plc、Neuraxpharm Pharmaceuticals SL、Mayne Pharma Group Ltd、Rusan Pharma Ltd 和 Teva Pharmaceutical Industries Ltd 是亚太阿片类药物市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Opioids Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Surging Chronic Pain Incidence
4.1.2 Increasing Geriatric Population
4.2 Market Restraints
4.2.1 Increasing Drug Abuse
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Impact of Drivers and Restraints:
5. Opioids Market - Asia Pacific Analysis
5.1 Asia Pacific Opioids Market Overview
5.2 Asia Pacific Opioids Market Revenue (US$ Million), 2020-2030
5.3 Asia Pacific Opioids Market Forecast Analysis
6. Asia Pacific Opioids Market Analysis - by Product
6.1 Immediate Release Short Acting Opioid
6.1.1 Overview
6.1.2 Immediate Release Short Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.1.2.1 Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
6.2 Extended Release Long-Acting Opioid
6.2.1 Overview
6.2.2 Extended Release Long-Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
6.2.2.1 Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
7. Asia Pacific Opioids Market Analysis - by Application
7.1 Pain Management
7.1.1 Overview
7.1.2 Pain Management: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Anesthesia
7.2.1 Overview
7.2.2 Anesthesia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Diarrhea Suppression
7.3.1 Overview
7.3.2 Diarrhea Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Cough Suppression
7.4.1 Overview
7.4.2 Cough Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.5 De-Addiction
7.5.1 Overview
7.5.2 De-Addiction: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Opioids Market Analysis - by Route of Administration
8.1 Oral
8.1.1 Overview
8.1.2 Oral: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Injectable
8.2.1 Overview
8.2.2 Injectable: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Transdermal Patch
8.3.1 Overview
8.3.2 Transdermal Patch: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Opioids Market Analysis - by Distribution Channel
9.1 Hospital Pharmacies
9.1.1 Overview
9.1.2 Hospital Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Retail Pharmacies
9.2.1 Overview
9.2.2 Retail Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Opioids Market - Country Analysis
10.1 Asia Pacific
10.1.1 Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
10.1.1.1 Asia Pacific: Opioids Market - Revenue and Forecast Analysis - by Country
10.1.1.2 China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 China: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.2.2 China: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.2.3 China: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.2.4 China: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.2.5 China: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.2.6 China: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.3 Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 Japan: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.3.2 Japan: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.3.3 Japan: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.3.4 Japan: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.3.5 Japan: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.3.6 Japan: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.4 India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 India: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.4.2 India: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.4.3 India: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.4.4 India: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.4.5 India: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.4.6 India: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.5 South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.1 South Korea: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.5.2 South Korea: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.5.3 South Korea: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.5.4 South Korea: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.5.5 South Korea: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.5.6 South Korea: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.6 Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.1 Australia: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.6.2 Australia: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.6.3 Australia: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.6.4 Australia: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.6.5 Australia: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.6.6 Australia: Asia Pacific Opioids Market Breakdown, by Distribution Channel
10.1.1.7 Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.7.1 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Product
10.1.1.7.2 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Immediate Release Short Acting Opioid
10.1.1.7.3 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Extended Release Long-Acting Opioid
10.1.1.7.4 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Application
10.1.1.7.5 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Route of Administration
10.1.1.7.6 Rest of Asia Pacific: Asia Pacific Opioids Market Breakdown, by Distribution Channel
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in Opioids Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Endo International plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Mallinckrodt Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Neuraxpharm Pharmaceuticals SL
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Mayne Pharma Group Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Rusan Pharma Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Teva Pharmaceutical Industries Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
?
List of Tables
Table 1. Asia Pacific Opioids Market Segmentation
Table 2. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Table 3. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 4. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 5. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 6. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 7. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 8. Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 9. Asia Pacific: Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 10. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 11. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 12. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 13. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 14. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 15. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 16. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 17. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 18. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 19. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 20. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 21. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 22. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 23. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 24. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 25. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 26. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 27. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 28. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 29. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 30. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 31. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 32. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 33. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 34. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 35. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 36. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 37. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 38. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 39. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 40. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Product
Table 41. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Immediate Release Short Acting Opioid
Table 42. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Extended Release Long-Acting Opioid
Table 43. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Application
Table 44. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Route of Administration
Table 45. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 46. Recent Organic Growth Strategies in Opioids Market
Table 47. Recent Inorganic Growth Strategies in the Opioids Market
Table 48. Glossary of Terms, Opioids Market
?
List of Figures
Figure 1. Asia Pacific Opioids Market Segmentation, by Country
Figure 2. Asia Pacific Opioids Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Asia Pacific Opioids Market Revenue (US$ Million), 2020-2030
Figure 5. Asia Pacific Opioids Market Share (%) - by Product (2022 and 2030)
Figure 6. Immediate Release Short Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Extended Release Long-Acting Opioid: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Opioids Market Share (%) - by Application (2022 and 2030)
Figure 9. Pain Management: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Anesthesia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Diarrhea Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Cough Suppression: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. De-Addiction: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Asia Pacific Opioids Market Share (%) - by Route of Administration (2022 and 2030)
Figure 16. Oral: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Injectable: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Transdermal Patch: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Asia Pacific Opioids Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 20. Hospital Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Retail Pharmacies: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Opioids Market, by Key Countries - Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Opioids Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Japan: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. India: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. South Korea: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Australia: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 29. Rest of Asia Pacific: Asia Pacific Opioids Market - Revenue and Forecast to 2030 (US$ Million)
Figure 30. Growth Strategies in Opioids Market
- Endo International plc
- Mallinckrodt Plc
- Neuraxpharm Pharmaceuticals SL
- Mayne Pharma Group Ltd
- Rusan Pharma Ltd
- Teva Pharmaceutical Industries Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific opioids market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific opioids market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific opioids market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.